Highmount Capital’s Amgen AMGN Stock Holding History

Highmount Capital’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$1.19M	Sell	7,780 -100	-1%	-$16K	0.31%	72
2015 Q1	$1.26M	Hold	7,880	–	–	0.31%	68
2014 Q4	$1.25M	Hold	7,880	–	–	0.31%	69
2014 Q3	$1.11M	Hold	7,880	–	–	0.28%	76
2014 Q2	$932K	Buy	7,880 +280	+4%	+$32.4K	0.22%	79
2014 Q1	$937K	Sell	7,600 -320	-4%	-$38.8K	0.22%	78
2013 Q4	$904K	Hold	7,920	–	–	0.21%	74
2013 Q3	$886K	Buy	7,920 +320	+4%	+$34.7K	0.22%	70
2013 Q2	$750K	Buy	+7,600	New	+$789K	0.2%	76

Other funds holding AMGN

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Highmount Capital's AMGN Position: Q2 2015 in Review

Highmount Capital reduced its Amgen (AMGN) stake by 1.3% in Q2 2015, selling an estimated $16K and leaving 7,780 shares worth $1.19M. The position accounts for 0.31% of the portfolio, ranked #72.

Highmount Capital first reported a position in AMGN in Q2 2013 and has held it in 9 quarters since. The position peaked at $1.26M in Q1 2015. 1,367 funds tracked by Wall St. Rank hold AMGN as of Q2 2015.

Highmount Capital held 7,780 shares of Amgen worth $1.19M as of Q2 2015.
Highmount Capital sold 100 Amgen shares in Q2 2015, an estimated $16K.
Amgen made up 0.31% of Highmount Capital's portfolio in Q2 2015, its #72 holding.
Highmount Capital first reported a position in Amgen in Q2 2013 and has held it in 9 quarters since.
Highmount Capital's Amgen position peaked at $1.26M in Q1 2015.
1,367 funds tracked by Wall St. Rank held Amgen as of Q2 2015.

Based on Highmount Capital's 13F filing for Q2 2015, filed 14 Aug 2015.